Ronald Andrews

Biography

Ronald has close to 30 years in governance and executive roles in the US Clinical and Molecular Diagnostics industry. He sits on the Board of Directors for several companies, both public and private, and is active on a number of charitable boards. He has extensive experience working with the US government in Washington and speaks regularly to industry groups. He served as the President of the Genetic Science Division for Thermo Fisher Scientific until December 2014. Prior to this he held a number of high profile executive roles including President of the Medical Sciences Venture within the Life Technologies Corporation, and he served as Chief Executive Officer of Clarient, a public company on the NASDAQ, which was sold to General Electric Healthcare in December 2010.”

Research Interest

 -